title: Intraoperative "no go" donor hepatectomy in living donor liver transplantation.
abstract: OBJECTIVE
  Although there are many reports on donor safety, there are few concerning aborted donations. We sought to analyze the "no go" donor hepatectomies in our liver transplantation center over 10 years' experience.
  
  
  METHODS
  Among 290 living donors brought to the operating room for liver graft harvest from March 2002 to April 2012, we examined the reasons to abandon the procedure, comparing their data with those of successful donors.
  
  
  RESULTS
  The donor operation was aborted in 5 cases various for reasons. The main reason for the abandonment of the operation process was poor liver quality: in single cases there was: poor liver quality due to a massive cirrhotic nodule observed by laparoscopy; serious steatosis of the liver, indicated by an intraoperative biopsy; and an unsuitable biliary anatomy, including 4 branches with 2 small ones. In another case, a biliary duct variation in the intraoperative cholangiogram showed a narrow crotch of the left and right ducts. In the 5th case, the donor would have been left with only a small remaining left lobe (<30%) if the right lobe had been harvested. All 5 donors proceeded to accept a right lobe hepatectomy. Comparison with the 285 successful donors showed no significant differences in preoperative demographic data. All 5 donors recovered without complication and were in good condition over long-term follow-up.
  
  
  CONCLUSIONS
  A low rate of "no go" donor hepatectomy can be achieved. There was no short- or long-term harm to the living donor owing to abandonment of the procedure.
authors: Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China.
authors: J Y
authors: JY
authors: Lei
authors: L N
authors: LN
authors: Yan
mesh_terms: D000328:Adult; D001659:Biliary Tract / Q000002:abnormalities*; D046148:Donor Selection; D005234:Fatty Liver / Q000150:complications* / Q000175:diagnosis; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects*; D006801:Humans; D007432:Intraoperative Period; D008103:Liver Cirrhosis / Q000150:complications* / Q000175:diagnosis; D016031:Liver Transplantation / Q000009:adverse effects* / Q000379:methods; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult